nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—Colchicine—TUBB—dilated cardiomyopathy	0.181	0.705	CrCbGaD
Tofisopam—PDE2A—cardiac ventricle—dilated cardiomyopathy	0.141	0.195	CbGeAlD
Tofisopam—PDE10A—heart—dilated cardiomyopathy	0.0926	0.128	CbGeAlD
Tofisopam—PDE2A—heart—dilated cardiomyopathy	0.0926	0.128	CbGeAlD
Tofisopam—PDE3A—cardiac ventricle—dilated cardiomyopathy	0.0803	0.111	CbGeAlD
Tofisopam—PDE2A—cardiac atrium—dilated cardiomyopathy	0.0792	0.11	CbGeAlD
Tofisopam—PDE3A—myocardium—dilated cardiomyopathy	0.0755	0.104	CbGeAlD
Tofisopam—PDE4A—heart—dilated cardiomyopathy	0.0637	0.0882	CbGeAlD
Tofisopam—PDE3A—heart—dilated cardiomyopathy	0.0527	0.0729	CbGeAlD
Tofisopam—Verapamil—SCN5A—dilated cardiomyopathy	0.048	0.187	CrCbGaD
Tofisopam—PDE3A—cardiac atrium—dilated cardiomyopathy	0.0451	0.0624	CbGeAlD
Tofisopam—Verapamil—SLC22A5—dilated cardiomyopathy	0.0277	0.108	CrCbGaD
Tofisopam—PDE2A—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000973	0.0469	CbGpPWpGaD
Tofisopam—PDE2A—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000788	0.038	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000737	0.0355	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TTN—dilated cardiomyopathy	0.000668	0.0322	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000597	0.0288	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000579	0.0279	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TTN—dilated cardiomyopathy	0.000506	0.0244	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—VCL—dilated cardiomyopathy	0.000492	0.0237	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000447	0.0215	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000439	0.0212	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000435	0.021	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—VCL—dilated cardiomyopathy	0.000373	0.018	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000362	0.0175	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000352	0.017	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TTN—dilated cardiomyopathy	0.000298	0.0144	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000259	0.0125	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000247	0.0119	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000222	0.0107	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000222	0.0107	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VCL—dilated cardiomyopathy	0.00022	0.0106	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—CD36—dilated cardiomyopathy	0.000211	0.0102	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000206	0.00994	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000201	0.00971	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000201	0.00971	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.0002	0.00962	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000199	0.00958	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000187	0.00903	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000187	0.00902	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000181	0.00874	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00017	0.00822	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000168	0.0081	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000168	0.0081	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000162	0.0078	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—CD36—dilated cardiomyopathy	0.00016	0.0077	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000156	0.00753	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000155	0.00746	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000153	0.00736	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000153	0.00736	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000151	0.00729	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—RAC1—dilated cardiomyopathy	0.000151	0.00726	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000147	0.00708	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000142	0.00684	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000137	0.00662	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000134	0.00646	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000132	0.00635	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000129	0.00623	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000126	0.00605	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000123	0.00591	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00012	0.00578	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000119	0.00573	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000119	0.00573	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000117	0.00566	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000114	0.0055	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000111	0.00537	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000111	0.00533	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ITGB1—dilated cardiomyopathy	0.00011	0.00532	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000109	0.00525	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000107	0.00516	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000102	0.00491	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000102	0.00491	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000102	0.00489	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—RAF1—dilated cardiomyopathy	9.98e-05	0.00481	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.9e-05	0.00477	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.9e-05	0.00477	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.52e-05	0.00459	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	9.46e-05	0.00456	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—CD36—dilated cardiomyopathy	9.42e-05	0.00454	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.25e-05	0.00446	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.25e-05	0.00446	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	9.21e-05	0.00444	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.17e-05	0.00442	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.15e-05	0.00441	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.09e-05	0.00438	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.01e-05	0.00435	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.01e-05	0.00435	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.99e-05	0.00434	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.99e-05	0.00434	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.92e-05	0.0043	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—RAC1—dilated cardiomyopathy	8.88e-05	0.00428	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.68e-05	0.00418	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.64e-05	0.00417	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	8.59e-05	0.00414	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.38e-05	0.00404	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	8.36e-05	0.00403	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.32e-05	0.00401	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AGT—dilated cardiomyopathy	8.26e-05	0.00398	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.12e-05	0.00391	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.1e-05	0.0039	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.83e-05	0.00377	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.62e-05	0.00367	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.56e-05	0.00365	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.46e-05	0.00359	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.43e-05	0.00358	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.22e-05	0.00348	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.11e-05	0.00343	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.93e-05	0.00334	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.92e-05	0.00333	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.74e-05	0.00325	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.74e-05	0.00325	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.58e-05	0.00317	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.56e-05	0.00316	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AGT—dilated cardiomyopathy	6.44e-05	0.0031	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.15e-05	0.00297	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.98e-05	0.00288	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—RAF1—dilated cardiomyopathy	5.88e-05	0.00284	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.77e-05	0.00278	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.73e-05	0.00276	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.65e-05	0.00272	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.61e-05	0.0027	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.51e-05	0.00266	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.46e-05	0.00263	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.46e-05	0.00263	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.36e-05	0.00258	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.31e-05	0.00256	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.31e-05	0.00256	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.24e-05	0.00252	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.19e-05	0.0025	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RAC1—dilated cardiomyopathy	5.11e-05	0.00246	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.09e-05	0.00246	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.08e-05	0.00245	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AGT—dilated cardiomyopathy	5e-05	0.00241	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.94e-05	0.00238	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.92e-05	0.00237	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AGT—dilated cardiomyopathy	4.88e-05	0.00235	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.87e-05	0.00235	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.78e-05	0.00231	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.47e-05	0.00215	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.2e-05	0.00202	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.09e-05	0.00197	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.98e-05	0.00192	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.93e-05	0.00189	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.88e-05	0.00187	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.47e-05	0.00167	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.42e-05	0.00165	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.39e-05	0.00163	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.38e-05	0.00163	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.33e-05	0.00161	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.09e-05	0.00149	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.06e-05	0.00148	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.01e-05	0.00145	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AGT—dilated cardiomyopathy	2.96e-05	0.00142	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AGT—dilated cardiomyopathy	2.87e-05	0.00139	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.7e-05	0.0013	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.54e-05	0.00122	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.38e-05	0.00115	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.32e-05	0.00112	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.32e-05	0.00112	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.3e-05	0.00111	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.05e-05	0.000989	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RAF1—dilated cardiomyopathy	2e-05	0.000962	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.41e-05	0.000678	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.37e-05	0.00066	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	6.24e-06	0.000301	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	6.08e-06	0.000293	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.47e-06	0.000264	CbGpPWpGaD
